PRC
ELV icon

Pearl River Capital’s Elevance Health ELV Stock Holding History

Pearl River Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,224
Closed -$1.21M – 120
2024
Q2 		$1.21M Buy
+2,224
New +$1.18M 0.19% 153
2023
Q4 		– Sell
-6,678
Closed -$2.91M – 514
2023
Q3 		$2.91M Sell
6,678
-2,525
-27% -$1.15M 0.46% 56
2023
Q2 		$4.09M Buy
9,203
+5,211
+131% +$2.4M 0.66% 27
2023
Q1 		$1.84M Buy
3,992
+199
+5% +$94.7K 0.29% 105
2022
Q4 		$1.95M Buy
+3,793
New +$1.93M 0.33% 93
2020
Q4 		– Sell
-2,084
Closed -$560K – 410
2020
Q3 		$560K Buy
+2,084
New +$561K 0.24% 147
2019
Q2 		– Sell
-854
Closed -$246K – 335
2019
Q1 		$246K Buy
+854
New +$247K 0.61% 35

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Pearl River Capital's ELV Position: Q3 2024 in Review

Pearl River Capital sold out of Elevance Health (ELV) in Q3 2024, closing a stake of 2,224 shares — an estimated $1.21M sold.

Pearl River Capital first reported a position in ELV in Q1 2019 and held it in 7 quarters. The position peaked at $4.09M in Q2 2023. 1,693 funds tracked by Wall St. Rank hold ELV as of Q3 2024.

  • Pearl River Capital reported no remaining Elevance Health position as of Q3 2024 after selling out during the quarter.
  • Pearl River Capital sold 2,224 Elevance Health shares in Q3 2024, an estimated $1.21M.
  • Pearl River Capital first reported a position in Elevance Health in Q1 2019 and held it in 7 quarters.
  • Pearl River Capital's Elevance Health position peaked at $4.09M in Q2 2023.
  • 1,693 funds tracked by Wall St. Rank held Elevance Health as of Q3 2024.

Based on Pearl River Capital's 13F filing for Q3 2024.